Express

Propanc Biopharma, a Listed Company, Plans to Acquire $100 Million Worth of Ethereum

Summary: According to reports, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) has announced plans to acquire $100 million worth of Ethereum in the next 12 months. The company stated that this move will enhance its corporate strategy in various areas such as cryptocurrency investments, drug development, and asset acquisitions.

According to reports, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) has announced plans to acquire $100 million worth of Ethereum in the next 12 months. The company stated that this move will enhance its corporate strategy in various areas such as cryptocurrency investments, drug development, and asset acquisitions.

Last Update:

Tags:
Link: Propanc Biopharma, a Listed Company, Plans to Acquire $100 Million Worth of Ethereum [Copy]

Last: Conflux Foundation Explores CFX Treasury Collaboration with Listed Companies, Proposing Lock-up Period of At Least 4 Years

Next: Tron Inc. Receives $110 Million Investment to Expand TRX Token Treasury

The Crypto Treasury Boom Meets Regulatory Chill: Is the DAT Frenzy Fading? 2 days ago

Nasdaq Takes Aim at 'Crypto-Flipping' Companies with Stricter Rules 6 days ago

BTC Weekly Outlook: The Oversold Bounce—A Bottom or a Shorting Opportunity? 9 days ago

The Making of a Political Darling: Is Chainlink’s Government Deal a Victory for Tech or... 13 days ago

Google Steps Into Blockchain: A New Front in the “Ledger Wars” 15 days ago